investment

This Bullish Trade Capitalizes On A Big Move By Astera Labs

RUSS BRITT

2 min read

0 likes

⚡ Quantum Brief

Astera Labs stock surged 10.5% on Monday after breaking above its 21-day and 50-day moving averages, signaling strong upward momentum in early February 2026. The company’s Relative Strength Rating entered the 90th percentile, reflecting outperformance relative to peers and reinforcing its bullish technical position. Its IBD SmartSelect Composite Rating was upgraded from 93 to 97 on Tuesday, further validating the stock’s improved fundamentals and market strength. Traders can capitalize on the rally with a lower-risk bull call spread, leveraging implied volatility to structure a cost-effective bullish options strategy. The move aligns with broader market interest in high-growth tech stocks, though investors should note the inherent risks in options trading.

AI Audio Summary

0:00 / 0:00

Click to play

Quantum News · Media Library

Understand this faster with AI

Ask ChatGPT

Research with Perplexity

Explain with Claude

Discuss on Grok

BREAKING: Stocks Mixed As Datadog, Marriott Rally Investors.com will undergo scheduled maintenance from 10:00 PM ET to 2:00 AM ET and some features may be unavailable. We apologize for any inconvenience.Astera Labs (ALAB) stock shot higher on Monday, surging 10.5% after breaking above its 21-day and 50-day moving averages on Friday. Shares also reached an important milestone, as its Relative Strength Rating jumped into the 90-plus percentile. Investors interested in taking some bullish exposure can do so with much lower risk through a bull call spread. Implied volatility is very… 2/09/2026 On Tuesday, Astera Labs got an upgrade for its IBD SmartSelect Composite Rating from 93 to 97. 2/09/2026 On Tuesday, Astera Labs got an upgrade for its IBD... Long known for generic drugs and fast-follower copycats, China is quickly emerging as a biotech trailblazer. (© Chris Gash)Get instant access to exclusive stock lists, expert market analysis and powerful tools with 2 months of IBD Digital for only $20!Get market updates, educational videos, webinars, and stock analysis.Learn how you can make more money with IBD's investing tools, top-performing stock lists, and educational content.Information in Investor’s Business Daily is for informational and educational purposes only and should not be construed as an offer, recommendation, solicitation, or rating to buy or sell securities. The information has been obtained from sources we believe to be reliable, but we make no guarantee as to its accuracy, timeliness, or suitability, including with respect to information that appears in closed captioning. Historical investment performances are no indication or guarantee of future success or performance. Authors/presenters may own the stocks they discuss. We make no representations or warranties regarding the advisability of investing in any particular securities or utilizing any specific investment strategies. Information is subject to change without notice. For information on use of our services, please see our Terms of Use.*Real-time prices by Nasdaq Last Sale. Real-time quote and/or trade prices are not sourced from all markets. Ownership data provided by LSEG and Estimate data provided by FactSet.IBD, IBD Digital, IBD Live, IBD Weekly, Investor's Business Daily, Leaderboard, MarketDiem, MarketSurge and other marks are trademarks owned by Investor's Business Daily, LLC.©2026 Investor’s Business Daily, LLC.

Read Original

Source Information

Source: Investor's Business Daily

Website: https://www.investors.com/feed/

Discussion

0 professional contributions

Be the first to add a constructive contribution.